Key Takeaways
- • Connecticut Governor Ned Lamont signed Senate Bill 196 on May 27, 2026, making Connecticut the first state to explicitly ban hospital sale-leaseback transactions, effective July 1, 2027.
- • Sale-leasebacks allow hospitals to sell owned real estate to third parties (often REITs) and then lease the property back, a structure critics argue enables private equity funds to extract capital and destabilize health systems under their control.
- • SB 196 also imposes additional restrictions on private equity involvement in hospitals, including requirements that PE firms hold no controlling interest, governance authority, or operational control, with attestation requirements effective February 15, 2027.
- • Massachusetts passed related legislation in 2025 that indirectly limited some hospital sale-leasebacks by preventing public health department licensing of acute care hospitals leasing their main campus from REITs, but Connecticut's law represents the first direct statutory prohibition of the practice.
- • The Private Equity Stakeholder Project characterizes Connecticut's ban as a landmark restriction targeting what PE critics describe as a primary extraction mechanism used by private equity to drain assets from healthcare providers.
Summary
Connecticut has enacted the nation's first explicit statutory ban on hospital sale-leaseback transactions, positioning itself at the forefront of state-level regulation targeting private equity involvement in healthcare. Governor Ned Lamont signed Senate Bill 196 on May 27, 2026, establishing a comprehensive framework that restricts both the structural mechanisms and governance arrangements through which private equity firms operate healthcare facilities.
The legislation's most significant provision prohibits hospitals from entering into sale-leaseback transactions effective July 1, 2027. In a sale-leaseback arrangement, a hospital sells its owned real estate to a third party—typically a real estate investment trust or other institutional investor—and subsequently leases the property back at market rates. Critics and legislators have identified this structure as a primary vehicle for private equity funds to extract capital from health systems, often leaving them operationally compromised and financially vulnerable. The Connecticut ban directly addresses this practice for the first time at the state level, according to representatives from the Private Equity Stakeholder Project (PESP), a nonprofit organization that monitors private equity transactions and advocates for increased transparency in the sector.
Beyond the sale-leaseback prohibition, SB 196 establishes broader restrictions on private equity governance and control. Effective February 15, 2027, hospitals must attest that private equity entities maintain no controlling interest in the facility, exercise no governance control or operational authority, and impose no mandates that interfere with clinician decision-making. These provisions aim to insulate clinical operations and institutional autonomy from PE-driven financial objectives.
Massachusetts implemented related but less direct restrictions in 2025, preventing its public health department from licensing acute care hospitals that lease their main campus from REITs. However, PESP representatives noted that Connecticut's approach represents the first bill that targets hospital sale-leasebacks as a discrete, prohibited practice. As private equity's role in healthcare delivery continues to draw legislative scrutiny across multiple states, Connecticut's comprehensive statutory framework may signal a broader shift toward explicit regulatory barriers to PE acquisition and restructuring strategies in the sector.
The legislation's most significant provision prohibits hospitals from entering into sale-leaseback transactions effective July 1, 2027. In a sale-leaseback arrangement, a hospital sells its owned real estate to a third party—typically a real estate investment trust or other institutional investor—and subsequently leases the property back at market rates. Critics and legislators have identified this structure as a primary vehicle for private equity funds to extract capital from health systems, often leaving them operationally compromised and financially vulnerable. The Connecticut ban directly addresses this practice for the first time at the state level, according to representatives from the Private Equity Stakeholder Project (PESP), a nonprofit organization that monitors private equity transactions and advocates for increased transparency in the sector.
Beyond the sale-leaseback prohibition, SB 196 establishes broader restrictions on private equity governance and control. Effective February 15, 2027, hospitals must attest that private equity entities maintain no controlling interest in the facility, exercise no governance control or operational authority, and impose no mandates that interfere with clinician decision-making. These provisions aim to insulate clinical operations and institutional autonomy from PE-driven financial objectives.
Massachusetts implemented related but less direct restrictions in 2025, preventing its public health department from licensing acute care hospitals that lease their main campus from REITs. However, PESP representatives noted that Connecticut's approach represents the first bill that targets hospital sale-leasebacks as a discrete, prohibited practice. As private equity's role in healthcare delivery continues to draw legislative scrutiny across multiple states, Connecticut's comprehensive statutory framework may signal a broader shift toward explicit regulatory barriers to PE acquisition and restructuring strategies in the sector.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.